Nebicapone Uses, Dosage, Side Effects and more
Nebicapone is under investigation in clinical trial NCT03097211 (Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg).
| Attribute | Details |
|---|---|
| Trade Name | Nebicapone |
| Generic | Nebicapone |
| Nebicapone Other Names | Nebicapone |
| Type | |
| Formula | C14H11NO5 |
| Weight | Average: 273.244 Monoisotopic: 273.063722458 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
